Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market Progresses for Huge Profits by 2026 With Top Companies AbbVie, Digestive Care, Janssen Pharmaceuticals, Anthera Pharmaceuticals, Allergan , AzurRx BioPharma
Ask For a Sample Copy : https://www.coherentmarketinsights.com/insight/request-sample/2020
EPI is associated with uncomfortable gastrointestinal (GI) symptoms such as bloating, gas, and oily diarrhea that floats and is difficult to flush. The symptoms of EPI may be similar to other gastrointestinal disorders such as Crohn’s disease, celiac disease, irritable bowel syndrome (IBS), ulcerative colitis, and small intestinal bacterial overgrowth (SIBO), which makes EPI difficult to diagnose. However, there are three major tests used for diagnosis of EPI that include, fecal elastase test, fecal fat test, and direct pancreatic function test.
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market – Drivers
Exocrine pancreatic insufficiency is associated with certain diseases and conditions such as chronic pancreatitis, cystic fibrosis, pancreatectomy, pancreatic cancer, gastrointestinal surgery, type I and type III C diabetes, and other conditions including autoimmune pancreatitis, celiac disease, and inflammatory bowel disease. Moreover, high prevalence of these conditions leads to EPI, which in turn fuels growth of exocrine pancreatic insufficiency (EPI) therapeutics market. For instance, according to a report by the Cystic Fibrosis Foundation, 2010, around 1,000 new cases of cystic fibrosis are diagnosed globally every year.
According to the American Cancer Society (ACS), in the U.S 2018, around 55, 440 people are expected to be diagnosed with pancreatic cancer, and around 44,330 people are expected to succumb to pancreatic cancer. Furthermore, according to the National Cancer Institute, from 2011 to 2015, 12.6 per 100,000 new cases of pancreatic cancer were registered, annually, in the U.S.
According to a report by the Diabetes.co.uk, 2018, EPI was more evident in the people with insulin-dependent diabetes. According to the same source, in 2003, a study conducted on around 1,000 diabetic patients found that insulin-dependent diabetes was more likely to produce abnormally low levels of exocrine pancreatic enzymes. Furthermore, between 25% and 50% of insulin-dependent diabetes patients were found to have developed exocrine pancreatic insufficiency.
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market – Competitive Analysis
Key players operating in the exocrine pancreatic insufficiency (EPI) therapeutics market include, AbbVie, Inc., Digestive Care, Inc., Janssen Pharmaceuticals, Inc., Anthera Pharmaceuticals, Inc., Allergan plc, AzurRx BioPharma, Inc., and others. Key players operating in this market are focused on product regulatory approvals and acquisition strategies to enhance their share in the market.
Request For Customization : https://www.coherentmarketinsights.com/insight/request-customization/2020
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market – Regional Analysis
Geographically, the global exocrine pancreatic insufficiency (EPI) therapeutics market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America is expected to dominate the global exocrine pancreatic insufficiency (EPI) therapeutics market due to increasing incidence and prevalence cases of these conditions occurring in this region. EPI is mostly characterized with its associated conditions such as cystic fibrosis, pancreatic cancer, chronic pancreatitis, gastrointestinal surgery, and others.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market Progresses for Huge Profits by 2026 With Top Companies AbbVie, Digestive Care, Janssen Pharmaceuticals, Anthera Pharmaceuticals, Allergan , AzurRx BioPharma here
News-ID: 1798753 • Views: 174
More Releases from Coherent Market Insights - Pharmaceutical Industry
Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around
More Releases for EPI
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease. Download the sample report at: https://www.pharmaproff.com/request-sample/1024 Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI
Global Epi Wafer Market 2018 - Nichia, EpiWorks, Norstel, OMMIC
Eminent Market, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
Epitaxial (Epi) Wafer Market Investment Research Report 2025
Epitaxy is a method used to grow or lay a single crystalline film or layer over a crystalline-based semiconductor surface or substrate. The deposited substance must have a definite acclimatization with regard to the crystal-based semiconductor substrate. Moreover, Chip developers applies either molten or vapor based foundations to produce such epitaxial over layers. An epitaxial wafer is a wafer of semiconducting substrate made by epitaxial growth for application in microelectronics,
Global Epi Wafer Market Report Analysis and Forecast 2017
ReportsWeb.com has announced the addition of the “Global Epi Wafer Market Research Report 2017-2022” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. The Global Epi Wafer Market Professional Survey Report 2017 is a professional and in-depth study on the current state of the Epi Wafer market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a
Epi Wafer Market 2017 - GlobalWafers, Nichia, EpiWorks
Apex Research, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
Epitaxial (Epi) Wafer Market 2017- ASM International, EpiWorks, Jenoptik
Marketreports.biz, recently published a detailed market research study focused on the "Epitaxial (Epi) Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epitaxial (Epi) Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epitaxial (Epi) Wafer industry, and estimates the future trend of Epitaxial